Trial Profile
A retrospective review of abiraterone in ketoconazole pre-treated versus ketoconazole-naive men with metastatic, castration resistant prostate cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jul 2014
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary) ; Ketoconazole
- Indications Prostate cancer
- Focus Therapeutic Use
- 07 Jul 2014 New trial record
- 03 Jun 2014 Results presented at the 50th Annual Meeting of the American Society of Clinical Oncology.